Technology

Esaote is launching MyLab Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology) in Barcelona, to be held Aug. 30 to Sept. 3. Configured for an extensive range of applications, MyLab Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting.

Home August 26, 2014
Home
News

New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with heart failure with reduced ejection fraction (HF-REF) will be presented at the world's largest cardiology congress, the European Society of Cardiology (ESC) Congress 2014, on Sunday, Aug. 31 at 2:30 a.m. EDT.

Home August 25, 2014
Home
Technology

Esaote is launching MyLab Gamma, a best-in-class, highly portable “green” cardiovascular ultrasound system at ESC Congress (European Society of Cardiology, Barcelona, Aug. 30-Sept. 3).

Home August 25, 2014
Home
Technology

August 22, 2014 — AliveCor announced the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AF), the most common form of cardiac arrhythmia. Now with the AliveCor Heart Monitor, free AliveECG app and AFib Detector, a serious medical condition can be detected entirely using a mobile device.

Home August 22, 2014
Home
News

Biotronik announced the first implantations worldwide of its new ICD and CRT-D series (implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators).

Home August 22, 2014
Home
News

Sunshine Heart Inc. announced that the current condition of a heart failure patient implanted with the C-Pulse System improved after six weeks of treatment, allowing him to attend his daughter's wedding.

Home August 22, 2014
Home
News

August 21, 2014 — Christie Medical Holdings and Wolfson Children’s Hospital announced an agreement to replace all current peripheral vascular access visualization devices at the hospital with 17 VeinViewers through Christie's FreshStart program.

Home August 21, 2014
Home
News

August 21, 2014 — diaDexus announced it has received notice from the U.S. Food and Drug Administration (FDA) that an administrative acceptance review was conducted on the traditional 510(k) submission of the PLAC Test for Lp-PLA2 Activity, and it was found to contain all of the necessary information needed to proceed with the substantive review.

Home August 21, 2014
Home
heart in chest with vital sign illustration_iStock_3875987Large_4
Feature

August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop in the rate of hospitalizations and deaths, according to a new study released in the journal Circulation. The results emphasize the value of recent efforts by the cardiovascular community to support the delivery of timely, high-quality care to patients.

Home August 21, 2014
Home
News

August 21, 2014 — Corindus Vascular Robotics announced the results of a retrospective study comparing use of radiation and contrast for patients enrolled in its CorPath PRECISE (Percutaneous Robotic-Enhanced Coronary Intervention) study to a matched traditional manual PCI (percutaneous coronary intervention) patient, published in the July 2014 issue of the Journal of Invasive Cardiology.

Home August 21, 2014
Home
News

Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.

Home August 21, 2014
Home
News

Cardiva Medical Inc. said it closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital. The company will use the proceeds of the Series 3 private equity financing and debt facility to expand commercial efforts for its Vascade vascular closure system in the United States.

Home August 21, 2014
Home
News

NorthStar Medical Radioisotopes LLC signed a non-exclusive letter of intent with GE Healthcare, a division of General Electric Co., marking further progress toward establishing the first existing commercially viable domestic source of the radioisotope 99molybdenum (99Mo).

Home August 20, 2014
Home
Technology

GE Healthcare introduces the Vscan with Dual Probe with the first of its kind 2-in-1 probe to give healthcare providers more uses for pocket ultrasound.

Home August 20, 2014
Home
U.S. Department of Justice Close Investigation PLATO Clinical Trial Ticagrelor
Feature

AstraZeneca announced it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial that tested the safety and effectiveness of the blood thinner ticagrelor (Brilinta).

Home August 20, 2014
Home
Subscribe Now